Skip to main content

Advertisement

Log in

Development and validation of prognostic nomograms in patients with adrenocortical carcinoma: a population-based study

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Background

Predicting the prognosis of patients with adrenocortical carcinoma (ACC) is difficult, due to its unpredictable behavior. The aim of this study is to develop and validate a nomogram to predict survival outcomes in patients with ACC.

Methods

Nomograms were established using the data collected from the Surveillance, Epidemiology, and End Results (SEER) database. Based on univariate and multivariate Cox regression analyses, we identified independent risk factors for overall survival (OS) and cancer-specific survival (CSS). Concordance indexes (c-indexes), the area under the receiver operating characteristics curve (AUC) and calibration curve were used to evaluate predictive performance of these models. The clinical use of nomogram was measured by decision curve analysis (DCA) and clinical impact curves.

Results

A total of 855 eligible patients, randomly divided into training (n = 600) and validation cohorts (n = 255), were included in this study. Based on the independent predictors, the nomograms were established and demonstrated good discriminative abilities, with C-indexes for OS and CSS were 0.762 and 0.765 in training cohorts and 0.738 and 0.758 in validation cohorts, respectively. The AUC and calibration plots also demonstrated a good performance for both nomograms. DCA indicated that the two nomograms provide clinical net benefits.

Conclusion

We unveiled the prognostic factors of ACC and developed novel nomograms that predict OS and CSS more accurately and comprehensively, which can help clinicians improve individual treatment, making proper clinical decisions and adjusting follow-up management strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Kebebew E, Reiff E, Duh QY, Clark OH, McMillan A (2006) Extent of disease at presentation and outcome for adrenocortical carcinoma: Have we made progress? World J Surg 30(5):872–878. https://doi.org/10.1007/s00268-005-0329-x

    Article  PubMed  Google Scholar 

  2. Fassnacht M, Kroiss M, Allolio B (2013) Update in adrenocortical carcinoma. J Clin Endocrinol Metab 98(12):4551–4564. https://doi.org/10.1210/jc.2013-3020

    Article  CAS  PubMed  Google Scholar 

  3. Icard P, Goudet P, Charpenay C et al (2001) Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons Study Group. World J Surg 25(7):891–897. https://doi.org/10.1007/s00268-001-0047-y

    Article  CAS  PubMed  Google Scholar 

  4. Ayala-Ramirez M, Jasim S, Feng L et al (2013) Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center. Eur J Endocrinol 169(6):891–899. https://doi.org/10.1530/EJE-13-0519

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Sharma E, Dahal S, Sharma P et al (2018) The characteristics and trends in adrenocortical carcinoma: a United States Population Based Study. J Clin Med Res 10(8):636–640. https://doi.org/10.14740/jocmr3503w

    Article  PubMed  PubMed Central  Google Scholar 

  6. Allolio B, Hahner S, Weismann D, Fassnacht M (2004) Management of adrenocortical carcinoma. Clin Endocrinol (Oxf) 60(3):273–287. https://doi.org/10.1046/j.1365-2265.2003.01881.x

    Article  Google Scholar 

  7. Zini L, Capitanio U, Jeldres C et al (2009) External validation of a nomogram predicting mortality in patients with adrenocortical carcinoma. BJU Int 104(11):1661–1667. https://doi.org/10.1111/j.1464-410X.2009.08660.x

    Article  PubMed  Google Scholar 

  8. Li Y, Bian X, Ouyang J, Wei S, He M, Luo Z (2018) Nomograms to predict overall survival and cancer-specific survival in patients with adrenocortical carcinoma. Cancer Manag Res 10:6949–6959. https://doi.org/10.2147/CMAR.S187169

    Article  PubMed  PubMed Central  Google Scholar 

  9. Cronin KA, Ries LAG, Edwards BK (2014) Preface. Cancer 120(S23):3755–3757. https://doi.org/10.1002/cncr.29049

    Article  PubMed  Google Scholar 

  10. Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10(21):7252–7259. https://doi.org/10.1158/1078-0432.CCR-04-0713

    Article  CAS  PubMed  Google Scholar 

  11. DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) (2004) Pathology and genetics of tumours of endocrine organs. IARC, Lyon

    Google Scholar 

  12. Moons KG, Altman DG, Reitsma JB et al (2015) Transparent reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med 162:W1–W73. https://doi.org/10.7326/M14-0698

    Article  PubMed  Google Scholar 

  13. Sauerbrei W, Boulesteix AL, Binder H (2011) Stability investigations of multivariable regression models derived from low- and high-dimensional data. J Biopharm Stat 21(6):1206–1231. https://doi.org/10.1080/10543406.2011.629890

    Article  PubMed  Google Scholar 

  14. Royston P, Altman DG (2013) External validation of a Cox prognostic model: Principles and methods. BMC Med Res Methodol. https://doi.org/10.1186/1471-2288-13-33

    Article  PubMed  PubMed Central  Google Scholar 

  15. Vickers AJ, Cronin AM, Elkin EB, Gonen M (2008) Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak 8:1–17. https://doi.org/10.1186/1472-6947-8-53

    Article  Google Scholar 

  16. Vickers AJ, Elkin EB (2006) Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 26(6):565–574. https://doi.org/10.1177/0272989X06295361

    Article  PubMed  PubMed Central  Google Scholar 

  17. Huang YQ, Liang CH, He L et al (2016) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol 34(18):2157–2164. https://doi.org/10.1200/JCO.2015.65.9128

    Article  PubMed  Google Scholar 

  18. Bilimoria KY, Shen WT, Elaraj D et al (2008) Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer 113(11):3130–3136. https://doi.org/10.1002/cncr.23886

    Article  PubMed  Google Scholar 

  19. Stojadinovic A, Ghossein RA, Hoos A et al (2002) Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. J Clin Oncol 20(4):941–950. https://doi.org/10.1200/JCO.2002.20.4.941

    Article  CAS  PubMed  Google Scholar 

  20. Harrison LE, Gaudin PB, Brennan MF (1999) Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection. Arch Surg 134(2):181–185. https://doi.org/10.1001/archsurg.134.2.181

    Article  CAS  PubMed  Google Scholar 

  21. Şişman P, Şahin AB, Peynirci H et al (2017) Adrenokortikal karsinom: Tek merkez deneyimi. Turkish J Urol 43(4):462–469. https://doi.org/10.5152/tud.2017.81598

    Article  Google Scholar 

  22. Wang S, Chen S-S, Gao W-C et al (2017) Prognostic factors of adrenocortical carcinoma: an analysis of the Surveillance Epidemiology and End Results (SEER) database. Asian Pac J Cancer Prev 18(10):2817–2823. https://doi.org/10.22034/APJCP.2017.18.10.2817

    Article  PubMed  PubMed Central  Google Scholar 

  23. Paton BL, Novitsky YW, Zerey M et al (2006) Outcomes of adrenal cortical carcinoma in the United States. Surgery 140(6):914–920. https://doi.org/10.1016/j.surg.2006.07.035

    Article  PubMed  Google Scholar 

  24. Vaidya A, Nehs M, Kilbridge K (2019) Treatment of adrenocortical carcinoma. Surg Pathol Clin 12(4):997–1006. https://doi.org/10.1016/j.path.2019.08.010

    Article  PubMed  Google Scholar 

  25. Sabolch A, Feng M, Griffith K, Hammer G, Doherty G, Ben-Josef E (2011) Adjuvant and definitive radiotherapy for adrenocortical carcinoma. Int J Radiat Oncol Biol Phys 80(5):1477–1484. https://doi.org/10.1016/j.ijrobp.2010.04.030

    Article  PubMed  Google Scholar 

  26. Fassnacht M, Hahner S, Polat B et al (2006) Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma. J Clin Endocrinol Metab 91(11):4501–4504. https://doi.org/10.1210/jc.2006-1007

    Article  CAS  PubMed  Google Scholar 

  27. Hescot S, Slama A, Lombes A et al (2013) Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells. Endocr Relat Cancer 20(3):371–381. https://doi.org/10.1530/ERC-12-0368

    Article  CAS  PubMed  Google Scholar 

  28. Fitzgerald M, Saville BR, Lewis RJ (2015) Decision curve analysis. JAMA 313(4):409–410. https://doi.org/10.1001/jama.2015.37

    Article  CAS  PubMed  Google Scholar 

  29. Kerr KF, Brown MD, Zhu K, Janes H (2016) Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use. J Clin Oncol 34(21):2534–2540. https://doi.org/10.1200/JCO.2015.65.5654

    Article  PubMed  PubMed Central  Google Scholar 

  30. Fassnacht M, Johanssen S, Quinkler M et al (2009) Limited prognostic value of the 2004 international union against cancer staging classification for adrenocortical carcinoma. Cancer 115(2):243–250. https://doi.org/10.1002/cncr.24030

    Article  PubMed  Google Scholar 

  31. Gaujoux S, Grabar S, Fassnacht M et al (2011) Β-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma. Clin Cancer Res 17(2):328–336. https://doi.org/10.1158/1078-0432.CCR-10-2006

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the seer database and the data gatherers in every registries.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yingbo Dai.

Ethics declarations

Conflict of interest

The authors have declared that no conflict of interest exists in this work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, H., Naji, Y., Yan, M. et al. Development and validation of prognostic nomograms in patients with adrenocortical carcinoma: a population-based study. Int Urol Nephrol 52, 1057–1071 (2020). https://doi.org/10.1007/s11255-020-02413-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-020-02413-1

Keywords

Navigation